Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 02 JUNE 2020

Canada's CIHR Called On To Step-Up To Fund Basic & Applied Health Research – New Knowledge & IP Is Essential

Smart & Biggar
Explore more from Smart & Biggar

CIHR has shown leadership in COVID-19 health research, for example, through launching special, rapid response grant funding for COVID-19 research in February and April 2020.

CanadaCoronavirus (COVID-19)
Noel Courage
Noel Courage
Author LinkedIn connections

CIHR has shown leadership in COVID-19 health research, for example, through launching special, rapid response grant funding for COVID-19 research in February and April 2020.  There is an opportunity for CIHR to further broaden its leadership and its impact on health research by reinstating its cancelled Spring 2020 Project Grant competition for all areas of health research. A path forward is summarized here, in a piece by Dr. Jim Woodgett. 

It is good to periodically review CIHR's mandate by law to support creation and dissemination of new health knowledge. The objectives of CIHR are stated in the Canadian Institutes of Health Research Act1 as follows:

Objective

s.4 The objective of the CIHR is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system, by:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Health Canada Updates Policies On Foreign Regulatory Actions, Summary Reporting, Compliance & Enforcement And Requests For New Data

Health Canada issued revised guidance on notifying Health Canada of foreign actions, effective October 1, 2026. The revised guidance clarifies the requirements to notify Health Canada of certain foreign regulatory actions specified in subsection C.01.050(2) of the Food and Drug Regulations in the specified foreign jurisdictions, which involve a serious risk of injury to human health and are relevant to the safety of the drug.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

Health Canada Obtains Permanent Injunction To Prevent Illegal Sale Of Injectable Peptides By Canlab Research

Health Canada has secured a permanent injunction against Canlab Research, a Quebec-based online retailer, preventing the company from manufacturing, distributing, or selling unauthorized injectable peptides in Canada. This enforcement action follows years of regulatory warnings and provisional court orders aimed at stopping the illegal sale of peptide drugs promoted with unproven health claims for anti-aging, weight loss, and athletic performance.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

A KTEP Ahead: Canada's New Mechanism For Advanced Examination Of Patent Applications

For a Canadian patent application to be examined, an applicant must file a request for examination with the Canadian Intellectual Property Office (CIPO). In most cases, the order in which applications are examined is based on the order that the requests for examination are received. An applicant may be able to accelerate examination of their patent application through several existing mechanisms, including advancing examination via special order, accelerating examination of applications related to green technology, and the Patent Prosecution Highway (PPH).
CanadaIntellectual Property
Smart & Biggar
Smart & Biggar